Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 59Terminated 4Withdrawn 1Unknown 1Recruiting 1Active not recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Lymphoid 1Gynecologic 1

Conditions

Sarcoma 60Gliosarcoma 19Glioblastoma 19Osteosarcoma 15Lymphoma 14Central Nervous System Neoplasms 13Dendritic Cell Sarcoma, Interdigitating 11Rhabdomyosarcoma 10Oligodendroglioma 10Neuroblastoma 10Neoplasms 10Lymphoma, Large B-Cell, Diffuse 10Brain Neoplasms 10Bone Neoplasms 10Astrocytoma 10Recurrence 9Breast Neoplasms 9Sarcoma, Ewing 8Precursor Cell Lymphoblastic Leukemia-Lymphoma 8Lymphoma, Non-Hodgkin 8Liposarcoma 8Glioma 8Burkitt Lymphoma 8Wilms Tumor 7Neoplasm Metastasis 7Melanoma 7Hodgkin Disease 7Gastrointestinal Stromal Tumors 7Ovarian Neoplasms 6Medulloblastoma 6

Interventions

nirogacestat 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × HIV Infections × Sarcoma × Clear all
NCT02137564 2015-07-23

Gamma Secretase Inhibitor PF-03084014 in Treating Patients With AIDS-Associated Kaposi Sarcoma

AIDS Malignancy Consortium

Phase 2 Withdrawn
Sarcoma

AIDS-related Kaposi sarcoma, Sarcoma, Kaposi, HIV Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡